STAGE IV RENAL PELVIS AND URETER CANCER AJCC V8
Clinical trials for STAGE IV RENAL PELVIS AND URETER CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV RENAL PELVIS AND URETER CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IV RENAL PELVIS AND URETER CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test Triple-Threat drug combo against Tough-to-Treat cancers
Disease control OngoingThis early-stage study is testing the safety and best doses of a combination of cancer drugs for people with advanced cancers of the urinary system (like bladder and kidney cancer) that have spread. The trial combines a pill (cabozantinib) that aims to block tumor growth with one…
Matched conditions: STAGE IV RENAL PELVIS AND URETER CANCER AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New drug combo aims to keep advanced bladder cancer at bay
Disease control OngoingThis large, late-stage trial is testing if adding a pill called cabozantinib to an immunotherapy drug (avelumab) is better than the immunotherapy alone for keeping advanced bladder cancer from growing or returning. It is for patients whose cancer did not worsen after their first …
Matched conditions: STAGE IV RENAL PELVIS AND URETER CANCER AJCC V8
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC